ASCO
Meet us at ASCO 2025, the leading event in cancer research!
We’re thrilled to join you at ASCO 2025 to learn more about the latest innovations in cancer care and share insights for advancing your oncology development program.
Whether you’re evaluating your development plans, seeking expert regulatory insights, or looking for a strategic clinical development partner to support your asset, our expert oncology development team can deliver solutions for a smarter, faster path to approval.
A session with our experts will offer insights derived from supporting more than 200 oncology studies over the past 5 years:
Input on commercial, regulatory, and clinical development strategy driven by deep therapeutic expertise
Discussion on key considerations for nonclinical, CMC, and toxicology planning
Strategic approaches for site selection and onboarding
Opportunities to leverage Premier’s technology suite to ensure clean, conclusive data
Help identifying roadblocks and solutions to move your asset forward faster
Meet Our Team
Elaina Haeuber, Senior Vice President, Oncology
More than 20 years of clinical research operations and project management experience
Ashley Herrick, PhD, Vice President, Oncology Program Strategy
Nearly 15 years of experience in oncology global clinical trial oversight and drug development across all phases
Meera Belur, Executive Director, Oncology Program Strategy
More than 20 years of experience in oncology clinical development, including development oversight for radioligand, CAR-T, and gene therapy assets
Dr. Sandy Shah, Vice President, Medical Affairs
Board-certified medical oncologist with over 10 years of clinical research experience
Charles Chrisawn, Executive Director, Diagnostics
Over 15 years of experience designing and leading diagnostic trials including sample collection, validation, and utility studies
Let’s explore how we can work together to accelerate innovation in cancer care. Fill out the form to reserve a meeting with our team.
We look forward to seeing you there!